Researchers addressed the need for long-term expression of CCR5-specific antibodies to establish protection from HIV using ...
Treatment with fidanacogene elaparvovec, a recombinant adeno-associated virus (AAV) vector developed for the treatment of hemophilia B, led to sustained expression of the high-activity factor IX ...
High-throughput virology, design of experiments, and small-molecule production enhancers optimize yield and increase ...
The efficacy of adeno-associated virus (AAV)-mediated gene therapy for the inner ear is fundamentally constrained by the natural tropism of viral vectors, which often lack the precision and efficiency ...
New expedited service line designed for biotechs with timeline constraints, launched in response to client demandCan ...
Affinia Therapeutics (“Affinia”), an innovative gene therapy company with a pipeline of first-in-class and/or best-in-class adeno-associated virus (AAV) gene therapies initially for devastating ...
Taysha Gene Therapies, Inc. (Nasdaq: TSHA) (Taysha or the Company), a clinical-stage biotechnology company focused on ...
Density gradient ultracentrifugation (DGUC) is commonly regarded as the gold standard for consistent separation of difficult ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results